diaziquone has been researched along with Cancer of Nasopharynx in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, Y; Guo, L; Guo, Q; Ke, J; Peng, H; Peng, XE; Su, G; Xu, Y | 1 |
| Chen, PJ; Hsu, CC; Lan, YY; Lin, SC; Lin, YL; Liu, FQ; Lo, SC; Wu, YT; Yu, SJ | 1 |
1 trial(s) available for diaziquone and Cancer of Nasopharynx
| Article | Year |
|---|---|
Thyroid V40 is a good predictor for subclinical hypothyroidism in patients with nasopharyngeal carcinoma after intensity modulated radiation therapy: a randomized clinical trial.
Topics: Humans; Hypothyroidism; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Quality of Life; Radiotherapy, Intensity-Modulated | 2023 |
1 other study(ies) available for diaziquone and Cancer of Nasopharynx
| Article | Year |
|---|---|
NAD(P)H:quinone Oxidoreductase 1 Is Involved in AZ-1-induced Apoptotic Effects in Nasopharyngeal Carcinoma TW01 Cells.
Topics: Caspase 3; Caspase 8; Caspase 9; Humans; NAD; NAD(P)H Dehydrogenase (Quinone); Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Quinones | 2023 |